<!DOCTYPE html>
<html>
<head>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<style>
* {
  box-sizing: border-box;
}
body {
  margin: 0;
  font-family: "Lato", sans-serif;
  /*agregar color oscuro para el fondo*/
  background: #f1f1f1;
}
  /* Header/Logo Title */
.bg-image {
  /* The image used */
  background-image:url('bg.jpg');
  
  /* Add the blur effect */
  filter: blur(8px);
  -webkit-filter: blur(8px);
  
  /* Full height */
  height: 100%; 
  
  /* Center and scale the image nicely */
  background-position: center;
  background-repeat: no-repeat;
  background-size: cover;
}

/* Position text in the middle of the page/image */
.bg-text {
  background-color: rgb(0,0,0); /* Fallback color */
  background-color: rgba(0,0,0, 0.4); /* Black w/opacity/see-through */
  color: white;
  font-weight: bold;
  border: 3px solid #f1f1f1;
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  z-index: 2;
  width: 80%;
  padding: 20px;
  text-align: center;
}
.header {
  padding: 1px;
  text-align: center;
  background: linear-gradient(to bottom, 	#254666 30%, #4d667f 100%);
  color: white;
  font-size: 20px;
  margin-left: 200px;
} 
.center {
  display: block;
  margin-left: auto;
  margin-right: auto;
  width: 50%;
}
  .sidebar {
  margin: 0;  
  padding: 0;
  width: 200px;
  background-color: #FFFFFF;
  position: fixed;
  height: 100%;
  overflow: auto;
}
.sidebar a {
  display: block;
  color: black;
  padding: 16px;
  text-decoration: none;
} 
.sidebar a.active {
  background-color: #294e71;
  color: white;
}
.sidebar a:hover:not(.active) {
  background-color: #4d667f;
  color: white;
}

div.content {
  margin-left: 200px;
  padding: 1px 16px;
  height: 1000px;
}

@media screen and (max-width: 700px) {
  .sidebar {
    width: 100%;
    height: auto;
    position: relative;
  }
  .sidebar a {float: left;}
  div.content {margin-left: 0;}
}

@media screen and (max-width: 400px) {
  .sidebar a {
    text-align: center;
    float: none;
  }
}
  .card {
   background-color: white;
   padding: 20px;
   margin-top: 10px;
   margin-left: 230px;
   margin-right:30px;
   margin-bottom: 10px;
   box-shadow: 5px 5px 5px #888888;
}
</style>
</head>
<body>

  
<div class="sidebar">
  <br>
  <img src="/media/Logo.jpg" alt="Logo" style="width:90%;max-width:500px" class="center">
  <a class="active" href="#1_about_us">About us</a>
  <a href="/2_research">Research</a>
  <a href="/3_publications">Publications</a>
  <a href="/4_members">Members</a>
  <a href="/5_join_us">Join us</a>
  <a href="/6_events">Events</a>
  <a href="/7_contact">Contact</a>
</div>
  
<div class="header">
  <h1>Ramírez Lab </h1>
  <p>Computational Biophysics, Bioinformatics & Drug Design</p>
  </div>


<div class="card">
  <h2>Welcome to the Ramírez Lab</h2>
  <div class="bg-image"></div>
  <p align="justify">We are a multidisciplinary group focusing on the study of biomolecular systems 
    by using both, computational and experimental approaches. We aim to use computational methods - broadening 
    the way to describe biology phenomena - to combine and use them together with wet lab analyses for 
    drug design and development processes. Our work involves collaboration with medicinal chemists, 
    biochemists, and biologists, and we are part of the Institute of Biomedical Sciences at Universidad 
    Autónoma de Chile.</p>
</div>
  
<div class="card">
  <h2>Active research areas:</h2>
  <li align="justify">Structural insights into the substrate specificity and transport mechanisms in the Nitrate/Peptide Transporter (NPF) Family</li><br> 
  <li align="justify">Targeting cancer polypharmacology</li><br>
  <li align="justify">Promiscuous-drug design of molecules targeting neurodegenerative diseases</li><br>
  <li align="justify">Ion occupancy in potassium channels</li><br>
  <li align="justify">Unraveling the role of the side-fenestration in ion channels gating</li><br>  
  <li align="justify">Understanding the binding mechanisms of endo and phytocannabinoids into the human CB1 receptor</li><br>
</div>

  
<div class="card">
  <h2>Latest publication</h2>
  <h3>Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine</h3>
  <p align="justify">TASK-3 potassium (K+) channels are highly expressed in the central nervous system, regulating the 
    membrane potential of excitable cells. TASK-3 is involved in neurotransmitter action and has been identified as an 
    oncogenic K+ channel. For this reason, the understanding of the action mechanism of pharmacological modulators of 
    these channels is essential to obtain new therapeutic strategies. In this study we describe the binding mode of the 
    potent antagonist PK-THPP into the TASK-3 channel. PK-THPP blocks TASK-1, the closest relative channel of TASK-3, 
    with almost nine-times less potency. Our results confirm that the binding is influenced by the fenestrations state 
    of TASK-3 channels and occurs when they are open. The binding is mainly governed by hydrophobic contacts between 
    the blocker and the residues of the binding site. These interactions occur not only for PK-THPP, but also for the 
    antagonist series based on 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine scaffold (THPP series). However, the marked 
    difference in the potency of THPP series compounds such as 20b, 21, 22 and 23 (PK-THPP) respect to compounds such 
    as 17b, inhibiting TASK-3 channels in the micromolar range is due to the presence of a hydrogen bond acceptor group 
    that can establish interactions with the threonines of the selectivity filter.</p>
</div>
  
<div class="card">
  <h2>Founding</h2>
  <p>FONDECYT No. 11180604 (2018): Structural insights into the substrate specificity and transport mechanisms in the Nitrate/Peptide Transporter (NPF) Family.</p>
</div>  
</body>
</html>
